Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Go back to Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
(NASDAQ: CRDF) Delayed: 1.09 +0.01 (0.93%)
Previous Close $1.08    52 Week High
Open $1.08    52 Week Low
Day High $1.10    P/E N/A 
Day Low $1.07    EPS
Volume 437,331